← Leaderboards
Matthew Schrag
Vanderbilt University Medical Center
$7,278,640
Attributed
$12,748,925
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,748,925 · 8
By mechanism
RF1$6,366,859 · 2
R01$3,621,695 · 2
K76$1,215,000 · 1
R56$738,781 · 1
R21$466,590 · 1
R03$340,000 · 1
Top collaborators
- Ethan Lippmann5 shared
- Rena A. S. Robinson4 shared
- Jeffrey M Spraggins4 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Jeffrey M Spraggins$21,090,147
- Mary Ellen Irene Koran$486,000
- Megan Aumann$78,040
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposBrainS DiseaseMolecularCerebral Amyloid AngiopathyHuman TissueBrain TissueImpaired CognitionMouse ModelEffective TherapyAmyloid Beta-ProteinSenile PlaquesDepositionPathologyCerebrumAgingBlood VesselsEpidemicLinkNeuropathologyCellsDementiaMembraneFunctional Disorder
Grant awards (17)
Perivascular fibroblasts, vascular fibrosis, and their contributions to cerebral amyloid angiopathy$1,517,868
RF1 · FY2025 · NS
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias$765,645
R01 · FY2025 · NS
Elucidating Molecular Drivers of Aging and Alzheimer's Disease via Multimodal Imaging Mass Spectrometry$678,767
R01 · FY2025 · AG
Elucidating Molecular Drivers of Aging and Alzheimer's Disease via Multimodal Imaging Mass Spectrometry$700,765
R01 · FY2024 · AG
Elucidating Molecular Drivers of Aging and Alzheimer's Disease via Multimodal Imaging Mass Spectrometry$713,793
R01 · FY2023 · AG
Defective lysosomal membrane fission mediates axonal lysosome accumulation in dystrophic neurites in Alzheimer's disease.$243,000
K76 · FY2023 · AG · contact PI
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias$170,184
RF1 · FY2023 · NS
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias$2,345,579
RF1 · FY2022 · NS
Perivascular fibroblasts, vascular fibrosis, and their contributions to cerebral amyloid angiopathy$2,333,228
RF1 · FY2022 · NS
Elucidating Molecular Drivers of Aging and Alzheimer's Disease via Multimodal Imaging Mass Spectrometry$762,725
R01 · FY2022 · AG
Defective lysosome acidification in dystrophic neurites in Alzheimer's disease contributes to failure of autophagy$738,781
R56 · FY2022 · AG · contact PI
Defective lysosomal membrane fission mediates axonal lysosome accumulation in dystrophic neurites in Alzheimer's disease.$243,000
K76 · FY2022 · AG · contact PI
Microvascular Network Degeneration in a Novel Mouse Model of Alzheimer's Disease and Cerebral Amyloid Angiopathy$466,590
R21 · FY2021 · AG · contact PI
Defective lysosomal membrane fission mediates axonal lysosome accumulation in dystrophic neurites in Alzheimer's disease.$243,000
K76 · FY2021 · AG · contact PI
Defective lysosomal membrane fission mediates axonal lysosome accumulation in dystrophic neurites in Alzheimer's disease.$243,000
K76 · FY2020 · AG · contact PI
Cerebral Microvascular Network Alterations in Alzheimer's Disease and Cerebral Amyloid Angiopathy$340,000
R03 · FY2019 · NS · contact PI
Defective lysosomal membrane fission mediates axonal lysosome accumulation in dystrophic neurites in Alzheimer's disease.$243,000
K76 · FY2019 · AG · contact PI